JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201697200 on May 28, 2002

J. Biol. Chem., Vol. 277, Issue 32, 29315-29320, August 9, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/32/29315    most recent
M201697200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Calcium-binding Loops of the Tandem C2 Domains of Synaptotagmin VII Cooperatively Mediate Calcium-dependent Oligomerization*

Mitsunori FukudaDagger §, Eisaku Katayama||**, and Katsuhiko Mikoshiba§Dagger Dagger

From the Dagger  Fukuda Initiative Research Unit, RIKEN (the Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan, the § Laboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan, the || Division of Biomolecular Imaging, Department of Basic Medical Science, Institute of Medical Science, University of Tokyo, Minato-ku Tokyo 108-8639, Japan, ** PRESTO, JST, Kawaguchi, Saitama 332-0012, Japan, and the Dagger Dagger  Division of Molecular Neurobiology, Department of Basic Medical Science, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

Received for publication, February 19, 2002, and in revised form, May 14, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synaptotagmin VII (Syt VII), a proposed regulator for Ca2+-dependent exocytosis, showed a robust Ca2+-dependent oligomerization property via its two C2 domains (Fukuda, M., and Mikoshiba, K. (2001) J. Biol. Chem. 276, 27670-27676), but little is known about its structure or the critical residues directly involved in the oligomerization interface. In this study, site-directed mutagenesis and chimeric analysis between Syt I and Syt VII showed that three Asp residues in Ca2+-binding loop 1 or 3 (Asp-172, Asp-303, and Asp-357) are crucial to robust Ca2+-dependent oligomerization. Unlike Syt I, however, the polybasic sequence in the beta 4 strands of the C2 structures (so-called "C2 effector domain") is not involved in the Ca2+-dependent oligomerization of Syt VII. The results also showed that the Ca2+-binding loops of the two C2 domains cooperatively mediate Syt VII oligomerization (i.e. the presence of redundant Ca2+-binding site(s)) as well as the importance of Ca2+-dependent oligomerization of Syt VII in Ca2+-regulated secretion. Expression of wild-type tandem C2 domains of Syt VII in PC12 cells inhibited Ca2+-dependent neuropeptide Y release, whereas mutant fragments lacking Ca2+-dependent oligomerization activity had no effect. Finally, rotary-shadowing electron microscopy showed that the Ca2+-dependent oligomer of Syt VII is "a large linear structure," not an irregular aggregate. By contrast, in the absence of Ca2+ Syt VII molecules were observed to form a globular structure. Based on these results, we suggest that the linear Ca2+-dependent oligomer may be aligned at the fusion site between vesicles and plasma membrane and modulate Ca2+-regulated exocytosis by opening or dilating fusion pores.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Neuronal exocytosis is an extremely rapid process precisely controlled by Ca2+ ions. Ca2+-binding proteins (so-called "Ca2+ sensors") must be present in the synaptic vesicle to achieve fusion of synaptic vesicles with the presynaptic plasma membrane in response to the rapid increase in Ca2+ ions (reviewed in Ref. 1). Genetic, structural, and biochemical studies during the past decade have indicated that synaptotagmin I (Syt I),1 an abundant synaptic vesicle protein, is the most likely candidate for the major Ca2+ sensor for neurotransmitter release in the central nervous system (Ref. 2; for reviews, see Refs. 3-6). Syt I contains one transmembrane domain and two C2 Ca2+-binding modules (the membrane-proximal C2A domain and membrane distal C2B domain) in the large cytoplasmic domain. The two C2 domains exhibit completely different biochemical properties in terms of phospholipid binding (3, 7) and play distinct roles in synaptic vesicle trafficking (8-10). Ca2+ binding to the C2A domain stimulates interaction with negatively charged phospholipids (2, 11-13), whereas Ca2+ binding to the C2B domain promotes clustering of the C2B domain in vitro (14-20). Whereas these Ca2+-dependent actions of the C2 domains are now believed to be an essential component of synaptic vesicle exocytosis, how they drive membrane fusion in response to Ca2+ remains unknown. The manner in which C2B oligomer is assembled (i.e. structure of Ca2+-dependent oligomer) on the synaptic vesicle is also unknown.

Syt has been found to comprise a large family of molecules both in vertebrates and in invertebrates (e.g. Drosophilia, Caenorhabditis elegans, and Arabidopsis thaliana) (Ref. 21 and references therein) and to share the same domain structure: an N-terminal single transmembrane domain, a spacer domain of varying length, two C2 domains, and a short carboxyl terminus (3-6). However, the Ca2+-binding ability of the C2A domain differs among murine Syt isoforms, and some of them fail to bind Ca2+ ions as a result of amino acid substitutions of key Asp/Glu residues responsible for Ca2+ binding (13, 22-24).2 The Ca2+-dependent oligomerization activity of the C2B domain and inositol polyphosphate binding activity also differs among the Syt isoforms (18, 19, 25, 26), and these diversities among the C2 domains of the Syt isoforms suggest that the members of the Syt family probably have distinct functions in membrane trafficking. However, with the exception of Syt I, the exact roles of the Syt isoforms (e.g. Syt III and Syt VII) in membrane trafficking are still a matter of controversy (27-31).

Our previous study showed that Syt VII has the strongest Ca2+-dependent self-oligomerization capacity in the Syt family (18, 19) and that both the C2A and C2B domains of Syt VII function as a Ca2+-dependent oligomerization site (i.e. Syt VII has "two hands") (32). Although Syt VII has recently been proposed to regulate several Ca2+-dependent processes (i.e. lysosomal exocytosis, insulin secretion in pancreatic beta -cells, and norepinephrine release in PC12 cells) (27, 28, 30, 33, 34), little is known about the functional involvement of the Ca2+-dependent self-oligomerization of Syt VII in these Ca2+-regulated events, the structure of the Ca2+-dependent oligomer, or the critical residues directly involved in the oligomerization interface. In this study, we attempt to identify the residues (or an oligomerization interface) critical to the Ca2+-dependent oligomerization of Syt VII and the functional relationship between the two C2 domains. We show by site-directed mutagenesis that, unlike Syt I, Ca2+-dependent homo- and hetero-oligomerization of Syt VII are cooperatively mediated by the Ca2+-binding loops of the two C2 domains, not by the putative C2 effector domains. Moreover, whereas expression of the wild-type cytoplasmic tandem C2 domains in PC12 cells inhibited Ca2+-dependent neuropeptide Y (NPY) release, mutant proteins incapable of Ca2+-dependent oligomerization had no effect on NPY release. Furthermore, we show by rotary-shadowing electron microscopy that the Ca2+-dependent Syt VII oligomer has a linear structure and is not a random aggregate. Based on these findings, we discuss how the Ca2+-dependent Syt oligomer regulates vesicular exocytosis.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmid Construction and Site-directed Mutagenesis of Mouse Synaptotagmin VII-- Mutant Syt VII molecules carrying an Asp-to-Asn substitution at amino acid position 172 (D172N), a D303N substitution, a D357N substitution, or a Lys-to-Gln substitution in the C2A domain (named the AQ mutation; K183Q, K184Q, and K186Q) were produced by PCR. The following pairs of oligonucleotides were used for amplification with pGEM-T-Syt VII as a template (35): 5'-GGTACTAGTAACCCCTTTGT-3' (D172N primer; sense), 5'-GCCATGGACATCGGGGGCACATCTTTCC-3' (D303N primer; sense), 5'-CAGGTAGATCTTGCCGATGACGTTGTT-3' (D357N primer; antisense), and 5'-AGATCTACCTGCTACCCGACCAGCAGCACCAACT-3' (AQ primer; sense). The PCR products were purified from an agarose gel on a Micro-Spin column (Amersham Biosciences, Inc., Buckinghamshire, UK) as described previously (35) and then directly inserted into the pGEM-T Easy vector (Promega, Madison, WI). After verifying the nucleotide sequences with a Hitachi SQ-5500 DNA sequencer, full-length Syt VII mutants were constructed by replacement of appropriate inserts at the appropriate restriction enzyme sites (underlined above) on the pGEM-T Easy vector. A mutant Syt VII carrying a Lys-to-Gln substitution in the C2B domain (named the BQ mutation; K320Q, K321Q, and K325Q) was essentially produced by means of two-step PCR techniques as described previously (25) using the following oligonucleotides: 5'-CTCTACGCGTTTGTCTTTAT-3' (BQ mutant primer 1; antisense) and 5'-ACGCGTAGAGAAACAGCAGACTGTGACACAGAA-3'(BQ mutant primer 2; sense). The resulting Syt VII mutant fragments were subcloned into a modified pEF-BOS mammalian expression vector with an N-terminal T7 or FLAG tag (7, 18, 36). All constructs were verified by DNA sequencing as described above. pEF-T7 (or FLAG)-VII-cyto and pEF-FLAG-Syt VI- cyto were prepared as described previously (18, 19, 37). Plasmid DNA was prepared using Wizard-mini preps (Promega) or Qiagen (Chatsworth, CA) Maxi prep kits.

Purification of the Cytoplasmic Domain of Synaptotagmin VII-- A glutathione S-transferase (GST) tag was added to the N terminus of Syt VII-cyto by PCR using the pGEX-2T vector (Amersham Biosciences) as a template: 5'-CGAGATCTATGTCCCCTATACTAGGTT-3' (GST 5' primer; sense) 5'-GGATCCCTTGTCGTCGTCGTCCTTGTAGTCCATAGATCCACGCGGAACCAGACCACCGGTACCACCGGAACCACCATCCGATTTTGGAGGATGGTC-3' (GST-Gly linker-thrombin-FLAG primer; antisense) (FLAG tag in boldface type, thrombin digestion site underlined, and Gly linker in italics; see also Fig. 6A). The purified PCR products were digested with BamHI and BglII (italicized and underlined above) and inserted into the BamHI site of pEF-T7-Syt VII-cyto (18) (named pEF-T7-GST-FLAG-Syt VII-cyto). T7-GST-FLAG-Syt VII-cyto proteins expressed in COS-7 cells (10 10-cm dishes) were solubilized with 1% Triton X-100, 50 mM HEPES-KOH, pH 7.2, and 250 mM NaCl and affinity-purified with glutathione-Sepharose (wet volume 20 µl; Amersham Biosciences). After extensively washing the beads with 10 mM HEPES-KOH, pH 7.2, thrombin (1 unit; Sigma) digestion was performed on the same column in 10 mM HEPES-KOH, pH 7.2, at 25 °C for 1 h. The eluate containing FLAG-Syt VII-cyto proteins was then incubated with benzamidine-Sepharose 6B (wet volume 20 µl; Amersham Biosciences) to remove the thrombin. The Triton X-100 was removed with Extracti-Gel detergent-removing gel (Pierce). Small debris was further removed by ultracentrifugation at 100,000 × g at 4 °C for 1 h (TLA 100.4 rotor, Optima TL Ultracentrifuge; Beckman- Coulter Inc.). Protein concentrations were estimated by 10% SDS-PAGE with bovine serum albumin as a reference.

NPY Release Assay-- NPY cDNA was a kind gift of Dr. Wolfhard Almers (38). The addition of the C-terminal T7-GST tag (GGSGGTGGMARMTGGQQMG + GST; Gly linker underlined) to NPY was essentially performed by PCR as described above (39). The resulting NPY-T7-GST fragments were subcloned into the NotI site of the modified pShooter vector (Invitrogen) (named pShooter-NPY-T7-GST) as described previously (40). PC12 cells (6-cm dish) were cotransfected with 4 µg each of pShooter-NPY-T7-GST and pEF-FLAG-Syt VII-cyto by using LipofectAMINE 2000 reagent (Invitrogen) according to the manufacturer's notes. Three days after transfection, cells were washed with prewarmed low KCl buffer (5.6 mM KCl, 145 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4) and then stimulated with either low KCl buffer or high KCl buffer (56 mM KCl, 95 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4) for 10 min at 37 °C. Released NPY-T7-GST was recovered by incubation with glutathione-Sepharose beads and analyzed by immunoblotting with horseradish peroxidase (HRP)-conjugated anti-T7 tag antibody. The intensity of the immunoreactive bands on x-ray film was quantified as described previously (18) and normalized by total expressed NPY-T7-GST. Total cell lysates were obtained by incubation with a lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, and 1% Nonidet P-40, and protease inhibitors). Under our experimental conditions, NPY-T7-GST was targeted to dense core vesicles (data not shown), and about 5% of total NPY-T7-GST was released only in a high KCl-dependent manner.

Electron Microscopy-- The specimens for electron microscopy were prepared by rotary shadowing as described previously (41). In brief, an aliquot of the purified Syt VII cytoplasmic fragment (about 50-100 µg/ml) was mixed with four volumes of 25 mM ammonium acetate containing 50% glycerol. The mixture was immediately sprayed onto the surface of freshly cleaved mica. Following rotary shadowing with Pt/C (elevation angle: 6 or 8°) and backing with pure carbon, replicas were floated off and were picked up onto copper grids. The images were recorded with a JEM-2000ES electron microscope (JEOL) at 80-kV acceleration voltage.

Miscellaneous Procedures-- Cotransfection of pEF-T7-Syts and pEF-FLAG-Syts into COS-7 cells (7.5 × 105 cells, the day before transfection, per 10-cm dish) was carried out with the LipofectAMINE Plus reagent according to the manufacturer's instructions (Invitrogen) (42). Proteins were solubilized with a buffer containing 1% Triton X-100, 250 mM NaCl, 50 mM HEPES-KOH, pH 7.2, 0.1 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin, and 10 µM pepstatin A at 4 °C for 1 h. T7-Syts were immunoprecipitated with anti-T7 tag antibody-conjugated agarose (Novagen; Madison, WI) in the presence of 2 mM EGTA or 1 mM divalent cations (MgCl2, CaCl2, SrCl2, and BaCl2) and/or various concentrations of NaCl as described previously (35). SDS-PAGE and immunoblotting with HRP-conjugated anti-T7 tag (Novagen) and anti-FLAG tag antibodies (Sigma) were also performed as described previously (18, 35, 42). The blots shown in this paper are representative of at least three independent experiments.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Oligomerization of Synaptotagmin VII Is Selectively Stimulated by Ca2+ and Mediated by Electrostatic Interaction-- If oligomerization of Syt VII via the two C2 domains is crucial to the Ca2+-regulated events previously described (27, 28, 30, 33, 34), oligomerization of Syt VII must be selectively stimulated by Ca2+ ions and not by other divalent cations. To confirm this, we first investigated the effect of divalent cations (1 mM) on self-oligomerization of Syt VII. The T7- and FLAG-tagged Syt VII cytoplasmic domains (Syt VII-cyto) were coexpressed in COS-7 cells, and the association between these two proteins was evaluated by the immunoprecipitation method (35, 42) in the presence of various divalent cations (1 mM). As expected, self-oligomerization of Syt VII was selectively promoted by Ca2+ ions, whereas Sr2+ and Ba2+ ions only marginally activated self-oligomerization. 1 mM Mg2+ ions had no effect at all (Fig. 1A, third panel). This divalent cation selectivity was quite similar to that of Syt I described previously (15, 16). Since the oligomerization of Syt VII was highly sensitive to ionic strength (failing to occur above 750 mM of NaCl), the Syt VII Ca2+-dependent oligomerization is most likely to be mediated by electrostatic interaction rather than hydrophobic interaction (Fig. 1B, third panel).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Ca2+ selectively promotes synaptotagmin VII clustering. A, effect of divalent cations on Ca2+-dependent oligomerization of Syt VII. B, Ca2+-dependent oligomerization of Syt VII is sensitive to ionic strength. pEF-T7-Syt VII-cyto and pEF-FLAG-Syt VII-cyto were cotransfected into COS-7 cells. The proteins expressed were solubilized with 1% Triton X-100 and immunoprecipitated with anti-T7 tag antibody-conjugated agarose (IP) in the presence of the divalent cations indicated (1 mM in A) or in the presence of 1 mM Ca2+ and the concentrations of NaCl indicated (in B) (32, 35). Co-immunoprecipitated FLAG-Syts were first detected with HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution; third panels). The same blots were stripped and reprobed with HRP-conjugated anti-T7 tag antibody to ensure loading of the same amounts of T7-Syt proteins (1:10,000 dilution; bottom panels). The top two panels indicate the total expressed T7-Syt VII-cyto and FLAG-Syt VII-cyto proteins (<FR><NU>1</NU><DE>80</DE></FR> volume; input) used for immunoprecipitation. Note that Ca2+ selectively promoted oligomerization of Syt VII (in A) and that it was highly sensitive to ionic strength (NaCl concentration). The positions of the molecular weight markers (× 10-3) are shown on the left.

Mutational Analysis of the Ca2+-binding Loops and the Putative C2 Effector Domains of Synaptotagmin VII-- Site-directed mutagenesis was performed to define the oligomerization interface of the Syt VII C2 domains (Fig. 2, A and B). We initially focused on the Lys cluster in the putative C2 effector domains, which is located in the beta 4 strand (Lys-183, Lys-184, and Lys-186 in the C2A domain and Lys-320, Lys-321, and Lys-325 in the C2B domain, corresponding to the "C2B effector domain" of Syt I) of the C2 beta -sandwich structure (16, 25, 43-46), because neutralization of these basic residues (Lys-to-Gln or Lys-to-Ala substitution) completely abrogated the Ca2+-dependent self-oligomerization of Syts I and II (16, 20). However, neutralization of all three basic residues in the C2A domain (named the AKQ mutation) and C2B domain (BKQ mutation) had no effect on the Ca2+-dependent self-oligomerization activity (Fig. 2C, third panel), although the AKQ mutation slightly increased the Ca2+-independent self-oligomerization activity.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of mutations in the putative C2 effector domains on Ca2+-dependent oligomerization of synaptotagmin VII. A, schematic representation of substitution mutants of Syt VII. The transmembrane domain (TM) and two C2 domains are represented by the open box and shaded boxes, respectively. Position numbers of amino acids are indicated on both sides. Amino acid substitutions are indicated by arrowheads. B, schematic representation of the structure of the C2 domains of Syt VII (modified from Ref. 44). The arrows represent eight beta  strands of the C2 domain (beta 1-beta 8). Three loops are formed at the top of the beta -sandwich structure, and two of them are involved in Ca2+ binding in the C2A domain of Syt I (43-45). The overall structure of the two C2 domains is quite similar, but an additional alpha -helix is present between the beta 7 and beta 8 strands in the C2B domain (45). Five Asp residues in the C2A domain (or in the C2B domain; parentheses) are thought to be crucial to Ca2+ binding, by analogy with the C2A domain of Syt I (44). KKK indicates the putative C2 effector domain in the beta 4 strands (16, 25). C, Ca2+-dependent self-oligomerization of Syt VII with the mutations in the C2 effector domains (AKQ and BKQ). pEF-T7-Syt VII-cyto and pEF-FLAG-Syt VII-cyto were cotransfected into COS-7 cells. The proteins expressed were solubilized with 1% Triton X-100 and immunoprecipitated with anti-T7 tag antibody-conjugated agarose (IP) in the presence or absence of 1 mM Ca2+ as described previously (32, 35). Co-immunoprecipitated FLAG-Syts were first detected with HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution; third panel in C). The same blot was stripped and reprobed with HRP-conjugated anti-T7 tag antibody to ensure loading of the same amounts of T7-Syt proteins (1:10,000 dilution; bottom panel in C). The top two panels indicate the total expressed T7-Syt VII-cyto and FLAG-Syt VII-cyto proteins (<FR><NU>1</NU><DE>80</DE></FR> volume; input in C) used for immunoprecipitation. Note that the mutations in the putative C2 effector domains (AKQ/BKQ) had virtually no effect.

We next focused on the Asp residues in putative Ca2+-binding loop 1 (Asp-172 in the C2A domain and Asp-303 in the C2B domain) and loop 3 (Asp-357 in the C2B domain) (43-45). The single Ca2+-binding loop mutations (D172N, D303N, or D357N) of the isolated C2 domain were sufficient to abolish the Ca2+-dependent self-oligomerization activity (Fig. 3A, third panel). To our surprise, however, the single Ca2+-binding loop mutations (D172N or D303N) of the full Syt VII cytoplasmic domain resulted in normal Ca2+-dependent self-oligomerization activity, whereas the double Ca2+-binding loop mutations (D172N and D303N) completely abrogated the Ca2+-dependent self-oligomerization activity (Fig. 3B, third panel). Similar results were obtained in regard to Ca2+-dependent hetero-oligomerization of Syt VII with Syt VI (compare Fig. 3, C and D, third panels); the single D172N mutation was neutral in regard to the interaction between Syt VII-cyto and Syt VI-cyto (Fig. 3D) but completely abrogated the interaction between Syt VII-C2A and Syt VI-cyto (Fig. 3C). In addition, the double Ca2+-binding loop mutant (D172N and D303N) was incapable of interacting with Syt VI-cyto even in the presence of Ca2+ (Fig. 3D). This result markedly contrasts with those of Syt I, because neutralization of the corresponding acidic (Asp) residues of Syt I in the Ca2+-binding loops enhanced the Ca2+-independent self-oligomerization activity (47). These findings strongly indicated that the fundamental mechanism of Ca2+-dependent self-oligomerization by Syt VII and Syt I is different, at least in terms of oligomerization interface, and we hypothesized that the two C2 domains of Syt VII cooperatively mediate Ca2+-dependent self-oligomerization (i.e. existence of a redundant Ca2+-binding site).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of mutations in the Ca2+-binding loops on self-oligomerization of the single C2 domain and tandem C2 domains of synaptotagmin VII. A, Ca2+-dependent self-oligomerization of the single C2 domain of Syt VII with Ca2+-binding loop mutations (D172N, D303N, or D357N). B, Ca2+-dependent self-oligomerization of the tandem C2 domains of Syt VII with the mutations in the Ca2+-binding loops (D172N and/or D303N). C, Ca2+-dependent hetero-oligomerization of T7-Syt VII-C2A mutant with FLAG-Syt VI-cyto. D, Ca2+-dependent hetero-oligomerization of T7-Syt VII-cyto mutants with FLAG-Syt VI-cyto. pEF-T7-Syts and pEF-FLAG-Syts were cotransfected into COS-7 cells. The proteins expressed were solubilized with 1% Triton X-100 and immunoprecipitated with anti-T7 tag antibody-conjugated agarose (IP) in the presence or absence of 1 mM Ca2+ as described previously (32, 35). Co-immunoprecipitated FLAG-Syts were first detected with HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution; third panels in A-D). The same blots were stripped and reprobed with HRP-conjugated anti-T7 tag antibody to ensure loading of the same amounts of T7-Syt proteins (1:10,000 dilution; bottom panels in A-D). The top two panels indicate the total expressed T7-Syt and FLAG-Syt proteins (<FR><NU>1</NU><DE>80</DE></FR> volume; input in A-D) used for immunoprecipitation. Note that the single mutation in the Ca2+-binding loops (D172N, D303N, or D357N) is sufficient to abolish oligomerization of the single C2 domain but not self-oligomerization of the tandem C2 domains, whereas the double mutations in the Ca2+-binding loops (D172N/D303N) completely abolished Ca2+-dependent homo- and hetero-oligomerization.

Ca2+-binding Loops of Two C2 Domains Cooperatively Mediate Ca2+-dependent Oligomerization of Synaptotagmin VII-- If this hypothesis were true, pairing of the C2A domain and C2B domain should be critical for Ca2+-dependent self-oligomerization of Syt VII, and to test this, we prepared a chimera between Syt VII and Syt I that contains the Syt I C2A domain (named Syt VII(S1A); see Fig. 4A). The Syt VII(S1A)-cyto protein showed weaker Ca2+-dependent self-oligomerization activity than that of the wild-type Syt VII protein (Fig. 4B, third panel), probably as a result of the loss of one hand (i.e. the C2A domain of Syt VII), because the Syt I C2A domain did not show Ca2+-dependent self-oligomerization activity (15, 16). It is noteworthy that the Syt VII(S1A)(D303N)-cyto protein showed Ca2+-independent self-oligomerization activity, the same as the Syt I Ca2+-binding mutation (47) (Fig. 4B, third panel). Thus, pairing of the C2A and C2B domains is crucial to efficient Ca2+-dependent self-oligomerization of Syt VII.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Ca2+-dependent oligomerization property of the C2A chimera between Syt VII and Syt I. A, schematic representation of the C2A chimera between Syt I and Syt VII (named Syt VII(S1A)). The transmembrane domain (TM), Syt I C2A domain, and Syt VII C2B domain are represented by the open box, hatched box, and shaded box, respectively. B, Ca2+-dependent self-oligomerization of Syt VII(S1A) mutants. pEF-T7-Syt VII(S1A)-cyto and pEF-FLAG-Syt VII(S1A)-cyto were cotransfected into COS-7 cells. The proteins expressed were solubilized with 1% Triton X-100 and immunoprecipitated with anti-T7 tag antibody-conjugated agarose (IP) in the presence or absence of 1 mM Ca2+ as described previously (32, 35). Co-immunoprecipitated FLAG-Syts were first detected with HRP-conjugated anti-FLAG tag antibody (1:10,000 dilution; third panel in B). The same blot was stripped and reprobed with HRP-conjugated anti-T7 tag antibody to ensure loading of the same amounts of T7-Syt proteins (1:10,000 dilution; bottom panel in B). The top two panels indicate the total expressed T7-Syt VII(S1A)-cyto and FLAG-Syt VII(S1A)-cyto proteins (<FR><NU>1</NU><DE>80</DE></FR> volume; input in B) used for immunoprecipitation.

Effect of Mutations in the Ca2+-binding Loops on Ca2+-dependent NPY Release in PC12 Cells-- We then investigated the involvement of Ca2+-dependent oligomerization of Syt VII in Ca2+-dependent NPY-T7-GST release by expression of wild-type or mutant (D172N/D303N) cytoplasmic fragments of Syt VII in PC12 cells. Expression of the wild-type Syt VII-cyto in PC12 cells resulted in about 50% inhibition of Ca2+-induced exocytosis, whereas expression of Syt VII-cyto(D172N/D303N) completely reversed the inhibitory effect (Fig. 5). Ca2+-independent NPY-T7-GST release was unaltered by the expression of recombinant proteins (data not shown). These results suggested a critical function of Ca2+-dependent oligomerization of the C2 domains in Ca2+-induced exocytosis.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 5.   Ca2+-triggered NPY release requires an intact Ca2+ binding site in the tandem C2 domains of synaptotagmin VII. PC12 cells expressing Syt VII tandem C2 domains were stimulated by high KCl buffer, and the NPY-T7-GST released was measured by immunoprecipitation as described under "Experimental Procedures." The results are expressed as percentage of NPY-T7-GST release compared with control samples without expression of recombinant proteins. Note that expression of the wild-type fragment dramatically reduced the Ca2+-dependent NPY-T7-GST release (*, p < 0.01, Student's unpaired t test) (open bar), whereas expression of the mutant protein (D172N/D303N) had no significant effect (closed bar). Bars indicate the mean ± S.E. of three determinations. The inset shows the similar expression levels of the wild-type and DN (D172N/D303N) mutant proteins visualized by HRP-conjugated anti-FLAG tag antibody. The arrowhead indicates the nonspecific interaction of anti-FLAG tag antibody. The results shown are representative of three independent experiments.

Structure of Ca2+-dependent Oligomerization of Synaptotagmin VII Visualized by Rotary-shadowing Electron Microscopy-- Finally, we attempted to visualize the structure of the Ca2+-dependent oligomer of Syt VII by rotary-shadowing electron microscopy. Since the bacterial recombinant Syt VII-cyto proteins were difficult to prepare due to inclusion bodies (data not shown), we used recombinant proteins from mammalian cultured cells for electron microscopy. The recombinant cytoplasmic domains of Syt VII fused to GST (Fig. 6A) were expressed in COS-7 cells and were affinity-purified as described under "Experimental Procedures." The purity of the recombinant Syt VII on the SDS-polyacrylamide gel was always greater than 95% (Fig. 6B).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   Purification of cytoplasmic fragments of synaptotagmin VII. A, schematic representation of the GST-tagged Syt VII cytoplasmic domain (amino acids 43-403). T7-tag, GST, and two C2 domains are represented by the black box, hatched box, and shaded boxes, respectively. B, pEF-T7-GST-FLAG-Syt VII-cyto was transfected into COS-7 cells. The proteins expressed were solubilized with 1% Triton X-100 and affinity-purified by glutathione-Sepharose beads. The GST tag was removed by thrombin digestion as described under "Experimental Procedures." Purified FLAG-Syt VII-cyto proteins were analyzed by 10% SDS-PAGE and staining with Coomassie Brilliant Blue R-250. The authenticity of the bands (FLAG-Syt VII-cyto) was confirmed by immunoblotting with HRP-conjugated anti-FLAG tag antibody (data not shown). The positions of the molecular weight markers (MW) (× 10-3) are shown on the left. WT, wild type.

In the absence of Ca2+, we observed only "globular structures," probably corresponding to the monomeric form of Syt VII molecules (arrowheads in the middle panel in Fig. 7). In the presence of Ca2+, however, "linear structures" of various length were observed in addition to the globular structures (Fig. 7, left panel and insets), indicating that Syt VII forms large Ca2+-dependent oligomers (or sometimes polymers), consistent with the results of our previous gel filtration analysis (32). These linear structures did not have branches and probably corresponded to the assembly of the globular structures observed in the absence of Ca2+ (Fig. 7, left panel). By contrast, no such linear structures were observed in the Syt VII(D172N/D303N) mutant specimens even in the presence of Ca2+ (globular structure, arrowheads in the right panel of Fig. 7), consistent with the results of immunoprecipitation described above (Fig. 3B). These results together with the results of immunoprecipitation (Figs. 2-4 and Ref. 18) and gel filtration analyses (32) indicated that the Ca2+-induced Syt VII oligomer is a large linear structure and not a random aggregate.


View larger version (147K):
[in this window]
[in a new window]
 
Fig. 7.   Rotary-shadowing electron microscopy of Ca2+-dependent synaptotagmin VII polymer. Left panel and insets, various lengths of Syt VII polymer (linear structures) in the presence of 1 mM Ca2+. Middle panel, globular structures (arrowheads) of Syt VII in the absence of Ca2+. Right panel, globular structures of Syt VII(D172N/D303N) mutants in the presence of Ca2+. Scale bar, 100 nm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In our previous study, we showed that a single C2 domain of Syt VII is sufficient for Ca2+-dependent homomultimerization and hetero-oligomerization with other Syt isoforms (18, 19, 32), but the functional relationship between the two C2 domains and the structure of the Syt VII oligomer had never been determined. In this paper, we have presented several lines of evidence indicating that the two C2 domains of Syt VII are not functionally independent and that the Ca2+-binding loops of the two C2 domains cooperatively mediate Ca2+-dependent oligomerization. First, mutation of the single Asp residue (D172N in the C2A domain or D303N in the C2B domain) in Ca2+-binding loop 1 abrogated the Ca2+-dependent self-oligomerization of the "isolated C2 domain" but was neutral in regard to the Ca2+-dependent self-oligomerization of the "tandem C2 domains" (Figs. 2 and 3). The tandem C2 domains with the double mutation (D172N/D303N), however, did not show Ca2+-dependent self-oligomerization, suggesting the presence of redundant Ca2+-binding site(s). Second, chimeric analysis between Syt I and Syt VII showed that pairing of the C2A and C2B domains is an important factor for efficient Ca2+-dependent oligomerization of Syt VII (Fig. 4). Based on these results, together with the recent crystallographic data showing that the Ca2+-binding regions of the two C2 domains of Syt III face each other (45), we propose that the Ca2+-binding loops of the two C2 domains directly contribute to formation of the oligomerization interface; Ca2+ binding to the Asp residues in the loops of the C2 structures changes the electrostatic charges around the loop domains, which may directly form the oligomerization interface between two C2 domains. This model is completely different from the model of Syt I (or II), which also showed Ca2+-dependent oligomerization mediated by the C2B effector domain but not the Ca2+-binding loops themselves (16, 20, 47). The structure of the Ca2+-dependent oligomer of Syt I is now under investigation in our laboratory, and it will be interesting to determine whether the Ca2+-dependent Syt I oligomer exhibits the same linear structure.

We also demonstrated the physiological importance of the Ca2+-dependent oligomerization of Syt VII by using the dominant negative approach (28, 30, 47). When the wild-type tandem C2 fragment was expressed in PC12 cells, Ca2+-dependent NPY release was significantly inhibited, most likely by competing endogenous Syt proteins. By contrast, the mutants lacking Ca2+-dependent oligomerization activity had no effect on NPY release (Fig. 5).

Although the exact role of the Ca2+-dependent oligomer of Syt VII in vesicular exocytosis is unknown, based on the structure of the Ca2+-dependent oligomer of Syt VII (i.e. the linear structure) visualized by rotary-shadowing electron microscopy (Fig. 7), it may be involved in dilation or opening of fusion pores by aligning to form a straight line at the fusion site between the vesicles and plasma membrane (48). Consistent with this hypothesis, Syt I and IV have recently been shown to modulate fusion pore kinetics in regulated exocytosis of PC12 cells (49). Further work is necessary to examine the effect of wild-type or mutant (D172N/D303N) expression on fusion pore kinetics to clarify the relationship between Syt VII oligomerization and fusion pore formation.

In summary, site-directed mutagenesis and chimeric analysis in this study demonstrated that the Ca2+-binding loops of the two C2 domains cooperatively mediate both Ca2+-dependent oligomerization of Syt VII and Ca2+-dependent NPY release. We have also shown that the Ca2+-dependent Syt VII oligomer is a linear structure, not an irregular random aggregate.

    ACKNOWLEDGEMENTS

We thank Dr. Wolfhard Almers (Vollum Institute, Portland, OR) for kindly donating a cDNA of NPY, Dr. Benoit R. Gauthier and Dr. Claes B. Wollheim (Geneva University Medical Center, Geneva, Switzerland) for helpful discussions, and Eiko Kanno and Yukie Ogata for technical assistance.

    FOOTNOTES

* This work was supported in part by a grant from the Human Frontier Science Program (to K. M.) and Ministry of Education, Science, and Culture of Japan Grant 13780624 (to M. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Fukuda Initiative Research Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Tel.: 81-48-462-4994; Fax: 81-48-462-4995; E-mail: mnfukuda@brain.riken.go.jp.

Published, JBC Papers in Press, May 28, 2002, DOI 10.1074/jbc.M201697200

2 Fukuda, M. (2002) Biochem. J. 10.1042/BJ20020484.

    ABBREVIATIONS

The abbreviations used are: Syt, synaptotagmin; GST, glutathione S-transferase; HRP, horseradish peroxidase; NPY, neuropeptide Y.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Bennett, M. R. (1999) Prog. Neurobiol. 59, 243-277[CrossRef][Medline] [Order article via Infotrieve]
2. Fernandez-Chacon, R., Konigstorfer, A., Gerber, S. H., Garcia, J., Matos, M. F., Stevens, C. F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T. C. (2001) Nature 410, 41-49[CrossRef][Medline] [Order article via Infotrieve]
3. Marquèze, B., Berton, F., and Seagar, M. (2000) Biochimie (Paris) 82, 409-420[Medline] [Order article via Infotrieve]
4. Südhof, T. C., and Rizo, J. (1996) Neuron 17, 379-388[CrossRef][Medline] [Order article via Infotrieve]
5. Fukuda, M., and Mikoshiba, K. (1997) Bioessays 19, 593-603[CrossRef][Medline] [Order article via Infotrieve]
6. Schiavo, G., Osborne, S. L., and Sgouros, J. G. (1998) Biochem. Biophys. Res. Commun. 248, 1-8[CrossRef][Medline] [Order article via Infotrieve]
7. Fukuda, M., Aruga, J., Niinobe, M., Aimoto, S., and Mikoshiba, K. (1994) J. Biol. Chem. 269, 29206-29211[Abstract/Free Full Text]
8. Mikoshiba, K., Fukuda, M., Moreira, J. E., Lewis, F. M. T., Sugimori, M., Niinobe, M., and Llinás, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10703-10707[Abstract/Free Full Text]
9. Fukuda, M., Moreira, J. E., Lewis, F. M. T., Sugimori, M., Niinobe, M., Mikoshiba, K., and Llinás, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10708-10712[Abstract/Free Full Text]
10. Fukuda, M., Moreira, J. E., Liu, V., Sugimori, M., Mikoshiba, K., and Llinás, R. R. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 14715-14719[Abstract/Free Full Text]
11. Davletov, B. A., and Südhof, T. C. (1993) J. Biol. Chem. 268, 26386-26390[Abstract/Free Full Text]
12. Chapman, E. R., and Jahn, R. (1994) J. Biol. Chem. 269, 5735-5741[Abstract/Free Full Text]
13. Fukuda, M., Kojima, T., and Mikoshiba, K. (1996) J. Biol. Chem. 271, 8430-8434[Abstract/Free Full Text]
14. Damer, C. K., and Creutz, C. E. (1996) J. Neurochem. 67, 1661-1668[Medline] [Order article via Infotrieve]
15. Sugita, S., Hata, Y., and Südhof, T. C. (1996) J. Biol. Chem. 271, 1262-1265[Abstract/Free Full Text]
16. Chapman, E. R., Desai, R. C., Davis, A. F., and Tornehl, C. K. (1998) J. Biol. Chem. 273, 32966-32972[Abstract/Free Full Text]
17. Osborne, S. L., Herreros, J., Bastiaens, P. I. H., and Schiavo, G. (1999) J. Biol. Chem. 274, 59-66[Abstract/Free Full Text]
18. Fukuda, M., and Mikoshiba, K. (2000) J. Biol. Chem. 275, 28180-28185[Abstract/Free Full Text]
19. Fukuda, M., and Mikoshiba, K. (2000) J. Biochem. (Tokyo) 128, 637-645[Abstract/Free Full Text]
20. Fukuda, M., Kabayama, H., and Mikoshiba, K. (2000) FEBS Lett. 482, 269-272[CrossRef][Medline] [Order article via Infotrieve]
21. Craxton, M. (2001) Genomics 77, 43-49[CrossRef][Medline] [Order article via Infotrieve]
22. Li, C., Ullrich, B., Zhang, J. Z., Anderson, R. G. W., Brose, N., and Südhof, T. C. (1995) Nature 375, 594-599[CrossRef][Medline] [Order article via Infotrieve]
23. von Poser, C., Ichtchenko, K., Shao, X., Rizo, J., and Südhof, T. C. (1997) J. Biol. Chem. 272, 14314-14319[Abstract/Free Full Text]
24. Fukuda, M., and Mikoshiba, K. (2001) Biochem. J. 354, 249-257[CrossRef][Medline] [Order article via Infotrieve]
25. Fukuda, M., Kojima, T., Aruga, J., Niinobe, M., and Mikoshiba, K. (1995) J. Biol. Chem. 270, 26523-26527[Abstract/Free Full Text]
26. Ibata, K., Fukuda, M., and Mikoshiba, K. (1998) J. Biol. Chem. 273, 12267-12273[Abstract/Free Full Text]
27. Martinez, I., Chakrabarti, S., Hellevik, T., Morehead, J., Fowler, K., and Andrews, N. W. (2000) J. Cell Biol. 148, 1141-1149[Abstract/Free Full Text]
28. Sugita, S., Han, W., Butz, S., Liu, X., Fernandez-Chacon, R., Lao, Y., and Südhof, T. C. (2001) Neuron 30, 459-473[CrossRef][Medline] [Order article via Infotrieve]
29. Mizuta, M., Kurose, T., Miki, T., Shoji-Kasai, Y., Takahashi, M., Seino, S., and Matsukura, S. (1997) Diabetes 46, 2002-2006[Abstract]
30. Gut, A., Kiraly, C. E., Fukuda, M., Mikoshiba, K., Wollheim, C. B., and Lang, J. (2001) J. Cell Sci. 114, 1709-1716[Abstract]
31. Saegusa, C., Fukuda, M., and Mikoshiba, K. (2002) J. Biol. Chem. 277, 24499-24505[Abstract/Free Full Text]
32. Fukuda, M., and Mikoshiba, K. (2001) J. Biol. Chem. 276, 27670-27676[Abstract/Free Full Text]
33. Gao, Z., Reavey-Cantwell, J., Young, R. A., Jegier, P., and Wolf, B. A. (2000) J. Biol. Chem. 275, 36079-36085[Abstract/Free Full Text]
34. Reddy, A., Caler, E. V., and Andrews, N. W. (2001) Cell 106, 157-169[CrossRef][Medline] [Order article via Infotrieve]
35. Fukuda, M., Kanno, E., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31421-31427[Abstract/Free Full Text]
36. Mizushima, S., and Nagata, S. (1990) Nucleic Acids Res. 18, 5332
37. Fukuda, M., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31428-31434[Abstract/Free Full Text]
38. Lang, T., Wacker, I., Steyer, J., Kaether, C., Wunderlich, I., Soldati, T., Gerdes, H. H., and Almers, W. (1997) Neuron 18, 857-863[CrossRef][Medline] [Order article via Infotrieve]
39. Fukuda, M., Kuroda, T. S., and Mikoshiba, K. (2002) J. Biol. Chem. 277, 12432-12436[Abstract/Free Full Text]
40. Fukuda, M., Ogata, Y., Saegusa, C., Kanno, E., and Mikoshiba, K. (2002) Biochem. J. 365, 173-180[CrossRef][Medline] [Order article via Infotrieve]
41. Katayama, E., and Ikebe, M. (1995) Biophys. J. 68, 2419-2428[Abstract/Free Full Text]
42. Fukuda, M., Kanno, E., Ogata, Y., and Mikoshiba, K. (2001) J. Biol. Chem. 276, 40319-40325[Abstract/Free Full Text]
43. Nalefski, E. A., and Falke, J. J. (1996) Protein Sci. 5, 2375-2390[Abstract]
44. Rizo, J., and Südhof, T. C. (1998) J. Biol. Chem. 273, 15879-15882[Free Full Text]
45. Sutton, R. B., Ernst, J. A., and Brunger, A. T. (1999) J. Cell Biol. 147, 589-598[Abstract/Free Full Text]
46. Mizutani, A., Fukuda, M., Niinobe, M., and Mikoshiba, K. (1997) Biochem. Biophys. Res. Commun. 240, 128-131[CrossRef][Medline] [Order article via Infotrieve]
47. Desai, R. C., Vyas, B., Earles, C. A., Littleton, J. T., Kowalchyck, J. A., Martin, T. F. J., and Chapman, E. R. (2000) J. Cell Biol. 150, 1125-1136[Abstract/Free Full Text]
48. Littleton, J. T., Bai, J., Vyas, B., Desai, R., Baltus, A. E., Garment, M. B., Carlson, S. D., Ganetzky, B., and Chapman, E. R. (2001) J. Neurosci. 21, 1421-1433[Abstract/Free Full Text]
49. Wang, C. T., Grishanin, R., Earles, C. A., Chang, P. Y., Martin, T. F. J., Chapman, E. R., and Jackson, M. B. (2001) Science 294, 1111-1115[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Patino-Lopez, X. Dong, K. Ben-Aissa, K. M. Bernot, T. Itoh, M. Fukuda, M. J. Kruhlak, L. E. Samelson, and S. Shaw
Rab35 and Its GAP EPI64C in T Cells Regulate Receptor Recycling and Immunological Synapse Formation
J. Biol. Chem., June 27, 2008; 283(26): 18323 - 18330.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. R. Gauthier, D. L. Duhamel, M. Iezzi, S. Theander, F. Saltel, M. Fukuda, B. Wehrle-Haller, and C. B. Wollheim
Synaptotagmin VII splice variants {alpha}, , and {delta} are expressed in pancreatic -cells and regulate insulin exocytosis
FASEB J, January 1, 2008; 22(1): 194 - 206.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
T. Tsuboi and M. Fukuda
Synaptotagmin VII modulates the kinetics of dense-core vesicle exocytosis in PC12 cells
Genes Cells, April 1, 2007; 12(4): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Itoh and M. Fukuda
Identification of EPI64 as a GTPase-activating Protein Specific for Rab27A
J. Biol. Chem., October 20, 2006; 281(42): 31823 - 31831.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
T. Itoh, M. Satoh, E. Kanno, and M. Fukuda
Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity.
Genes Cells, September 1, 2006; 11(9): 1023 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Bhalla, W. C. Tucker, and E. R. Chapman
Synaptotagmin Isoforms Couple Distinct Ranges of Ca2+, Ba2+, and Sr2+ Concentration to SNARE-mediated Membrane Fusion
Mol. Biol. Cell, October 1, 2005; 16(10): 4755 - 4764.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Hui, J. Bai, P. Wang, M. Sugimori, R. R. Llinas, and E. R. Chapman
Three distinct kinetic groupings of the synaptotagmin family: Candidate sensors for rapid and delayed exocytosis
PNAS, April 5, 2005; 102(14): 5210 - 5214.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Grass, S. Thiel, S. Honing, and V. Haucke
Recognition of a Basic AP-2 Binding Motif within the C2B Domain of Synaptotagmin Is Dependent on Multimerization
J. Biol. Chem., December 24, 2004; 279(52): 54872 - 54880.
[Abstract] [Full Text] [PDF]


Home page